Oscar Health Inc. (OSCR) Tops Q4 EPS by 6c; offers guidance

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.66), $0.06 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Oscar Health Inc. sees FY2024 revenue of $8.3-8.4 billion, versus the consensus of $7.265 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI